|
|
 |

½ÅÀϰí / ¼¿ï´ë °æ¿µ

¿µÈȸ°è¹ýÀÎ
Çѱ¹ÀºÇà Á¶»çºÎ, Çö´ëÁõ±Ç M&AÆÀÀå
Çö)Á¤ÀÏȸ°è¹ýÀÎ ´ëÇ¥ÀÌ»ç
Çö)´ë¿ìÂ÷ÆÇ¸Å °¨»çÀ§¿øÀå

KDS °æ¿µÀü·« ÀÚ¹® ¹× 5õ¸¸ºÒ ¿ÜÀÚ À¯Ä¡
Ú¸ BT±â¾÷ÀÎ TissueGine,Inc 5¹é¸¸ºÒ ÅõÀÚ À¯Ä¡
´ëÈ£¿¡ÀÌ¿¤ ¹× ³²¼±È¨¿þ¾î ±â¾÷ ºÐÇÒ ¹× Àμö ÀÚ¹®
Çѱ¹Æ¼Å¸´½°ø¾÷, ¿ì¸®Ä³ÇÇÅ» Àμö ÀÚ¹®
|
|
|

 |

Áß¾Ó´ë °æ¿µÇÐ ¼®»ç

»êµ¿È¸°è¹ýÀÎ
Çö)Á¤ÀÏȸ°è¹ýÀÎ º£Æ®³² ÀÚ¹®ÆÀÀå

±ÝÀ¶±â°ü ½Ç»ç ¹× °¨»ç ¾÷¹«
ºÎµ¿»ê °³¹ß ¹× ½ÅŹ ÄÁ¼³ÆÃ
|
|
|

 |

´ë±¸ ¼º±¤°í / ¼º±Õ°ü´ë °æ¿µ

»êµ¿KPMG / ¼¼Á¾È¸°è¹ýÀÎ
Çö)Á¤ÀÏȸ°è¹ýÀÎ °ü¸®ÃѰý

¹ýÁ¤°ü¸® Á¤¸®À§¿ø (ÅëÀϱ׷ì, µÎ·¹±×·ì µî)
±â¾÷±¸Á¶Á¶Á¤ ¾÷¹« (º£ºñ¶ó, CTI¹ÝµµÃ¼, »ïÀͰǼ³ µî)
M&A ¾÷¹« (³²¼±¾Ë¹Ì´½, Çѱ¹Æ¼Å¸´½ µî ÀμöÀÚ¹®)
|
|
|

 |

ºÎ»ê ºÎ»ê°í / ¿¬¼¼´ë °æ¿µ

»êµ¿KPMG / »ïÁ¤È¸°è¹ýÀÎ
ÇÁ¸®ÁòÀκ£½ºÆ®¸ÕÆ® ´ëÇ¥ÀÌ»ç
Çö)Á¤ÀÏȸ°è¹ýÀÎ ½É¸®½ÇÀå

M&A ÀÚ¹® ¾÷¹« (¿ì¸®Ä³ÇÇÅ», ³²¼±È¨¿þ¾î, TGº¥ÃÄ, ¼ö»êÁß°ø¾÷, ½Å¿ø,
¼¼½Å, ³ª»ê, µî)
±â¾÷±¸Á¶Á¶Á¤ ¾÷¹« (¼±¤, ¿ì¼º½Äǰ µî)
Due Diligence (±â¾ÆÀÚµ¿Â÷, Çö´ëÀ¯È, ´ë°æÅ×Å©³ë½º µî)
Anti-dumping ¾÷¹« (SKC, °¿ø»ê¾÷, °íÇÕ µî)
NPLÆò°¡ ¹× ÀμöÀÚ¹®(KAMCO Auction, ¼ö»êÁß°ø¾÷ µî)
|
|
|

 |

¼º±Õ°ü´ë °æ¿µÇÐ ¼®»ç

»ïÀÏȸ°è¹ýÀÎ / ´ëÁÖȸ°è¹ýÀÎ

±â¾÷°¡Ä¡Æò°¡ ¹× °¨»ç
|
|
|

 |

Áß¾Ó´ë °æ¿µ

»êµ¿KPMG / ¿µÈȸ°è¹ýÀÎ
Çö) Á¤ÀÏȸ°è¹ýÀÎ SOCÀÚ¹®ÆÀÀå
Çö) ÁÖ½Äȸ»ç ³ª¿ìÄÞ »ç¿ÜÀÌ»ç

ºÎ»êÁ¤º¸°í¼Óµµ·Î±¸Ãà BTL»ç¾÷(Á¤º¸Åë½ÅºÐ¾ß 1È£, ±¸Ãà¿Ï·á)
SOC ¹Î°£ÅõÀÚ»ç¾÷ »ç¾÷¼º °ËÅä(º¹ÇÕȯ½Â¼¾ÅÍ, ·Îº¿·£µå, CCTV, PSD µî)
Á¾ÇÕÀ¯¼±¹æ¼Û »ç¾÷°èȹ¼ÀÛ¼º/Due Diligence/M&A
¿Ü±¹(¿ÜÅõ)¹ýÀÎ ¼³¸³/¼¼¹«(±¹Á¦Á¶¼¼)/û»ê
|
|
|

 |

ºÎ»ê Çý±¤°í / ¼¿ï´ë ¼öÀÇÇаú

Çö)Á¤ÀÏȸ°è¹ýÀÎ °¨»ç 1ÆÀÀå

¿ì¸®Ä³ÇÇÅ», ´ë¸²¼ö»ê, ³ª»ê, µ¿ÇØÆÞÇÁ µî M&A ÀÚ¹®
¿ì¸®Ä³ÇÇÅ»,´ë°æÅ×Å©³ë½º,Æò»ê¿¡½º¾ÆÀÌ µî Due Diligence
³ª¸ðÅØ ÄÚ½º´Ú IPO Áö¿ø¾÷¹«
Á¦·Î¿øÀÎÅÍ·¢Æ¼ºê ÇÕº´À» ÅëÇÑ ¿ìȸ»óÀå ÀÚ¹®
Áß±¹ ÆÄÀÎÅØ, ½ÅÀÏÀ¯ÇѰø»ç ȸ°è°¨»ç ¹× ³»ºÎÅëÁ¦ ÀÚ¹®
¹Ì±¹ ¹ÙÀÌ¿Àº¥Ã³ TissueGene,inc. ÅõÀÚÀ¯Ä¡ ÀÚ¹®
|
|
|

 |

¼°´ë ¼öÇаú

½ÅÇÑâ¾÷ÅõÀÚ(ÁÖ)
Çö)Á¤ÀÏȸ°è¹ýÀÎ °¨»ç2ÆÀÀå

¾Æ³²Á¤º¸±â¼úµî °¨»ç ¹× ¼¼¹«Á¶Á¤
¼¼°¡µî M&A ¹× ÇÕº´ÀÚ¹®
¿ì¿µÀ¯¾Ð, SCCµî ½Ç»ç (Due Diligence)
ÅÂÈ£·»Æ®Ä«µî ±â¾÷°¡Ä¡Æò°¡
|
|
|

 |

¼¿ï´ë½Å°í / Áß¾Ó´ëÇб³ ÀÀ¿ëÅë°èÇаú

ÇÑ¿µÈ¸°è¹ýÀÎ
Çö)Á¤ÀÏȸ°è¹ýÀÎ °¨»ç3ÆÀÀå

¿ì¸®Ä³ÇÇÅ»/ Çö´ë¾àǰ/ Ȩij½ºÆ® °¨»ç ¹× ¼¼¹«Á¶Á¤
SCÁ¦ÀÏÀºÇà/ KB½Å¿ëÁ¤º¸/ ±â¸¢ÀüÀÚ µî ³»ºÎȸ°è°ü¸®Á¦µµ ±¸Ãà
ÄÚ½º¸ðÈÇÐ IFRS ±¸Ãà ÄÁ¼³ÆÃ
Due Diligence (KHE µî)
±â¾÷°¡Ä¡Æò°¡ (ž翬¸¶ µî)
¹Ì±¹ ¹ÙÀÌ¿Àº¥Ã³ Tissue Gene Inc. ÅõÀÚÀ¯Ä¡ ÀÚ¹®
ºñ¿µ¸®¹ýÀÎ ¼³¸³ ¹× Tax ÀÚ¹®
|
|
|

 |

´ëõ°í/ ÀÎÇÏ´ë °æ¿µÇаú

Çö)Á¤ÀÏȸ°è¹ýÀÎ °¨»ç3ÆÀ

¿ì¸®Ä³ÇÇÅ» µî °¨»ç ¹× ¼¼¹«Á¶Á¤
ÄÚ½º¸ðÈÇÐ IFRS ±¸Ãà ÄÁ¼³ÆÃ
ÇüÁö¾îÆä·² µî ³»ºÎȸ°è°ü¸®Á¦µµ ±¸Ãà ÀÚ¹®
ÀÌ³ë¿¥ÅØ ±â¾÷°¡Ä¡Æò°¡ ¹× SCC Due Diligence
|
|
|

 |

´ëÀϿܰí/ Çѱ¹¿Ü´ë °æÁ¦Çаú

Çö)Á¤ÀÏȸ°è¹ýÀÎ °¨»ç2ÆÀ

¿ì¸®Ä³ÇÇÅ»/ ÄÚ½º¸ðÈÇÐ/ ¾Æ³²Á¤º¸±â¼ú µî °¨»ç ¹× ¼¼¹«ÀÚ¹®
ÄÚ½º¸ðÈÇÐ/ ´ëÈ£¿¡ÀÌ¿¤ IFRS ±¸Ãà ÄÁ¼³ÆÃ
Due Diligence (KHE µî)
|
|
|

 |

ÃæºÏ Á¦Ãµ°í/ Ãæ³²´ë °æÁ¦Çаú

Çö)Á¤ÀÏȸ°è¹ýÀÎ °¨»ç2ÆÀ

´ëÈ£¿¡ÀÌ¿¤/ ¾Æ³²Á¤º¸±â¼ú/ ¸¶·ç¸ÁÄÚ¸®¾Æ µî °¨»ç ¹× ¼¼¹«ÀÚ¹®
ÄÚ½º¸ðÈÇÐ/ ´ëÈ£¿¡ÀÌ¿¤ IFRS ±¸Ãà ÄÁ¼³ÆÃ
Due Diligence(ÅÂÈ£·»Æ®Ä« µî)
M&A ¹× ÇÕº´ÀÚ¹®(¼¼°¡ µî)
|
|
|

 |

Áß¾Ó°í/ °æÈñ´ë °æ¿µÇкÎ

ÇÑ¿µÈ¸°è¹ýÀÎ
Çö)Á¤ÀÏȸ°è¹ýÀÎ FASÆÀ

´É·ü±³À° µî ´Ù¼öÀÇ È¸°è°¨»ç ¹× ¼¼¹«¾÷¹«
Due Diligence(KHE µî)
¿¡ÀÌÇÁ·ÎÅ×Å©³î·ÎÁö M&A ¹× ÇÕº´ÀÚ¹®
|
|
|

 |

Áß¾Ó´ëÇб³ °æ¿µÇаú/°í·Á´ëÇб³´ëÇпø À繫·Ð Àü°ø.¼®»ç

¾ÈÁøÈ¸°è¹ýÀÎ/»êµ¿È¸°è¹ýÀÎ
µ¿¾Æ»ý¸í ÅõÀ¶ÀÚºÎ
±¸·Î±¸ Áö¹æ¼¼½ÉÀÇÀ§¿øÈ¸ À§¿ø
Çö)Á¤ÀÏȸ°è¹ýÀÎ ±¸·ÎÁöÁ¡

»ï¼ºÈÀç µî ´Ù¼öÀÇ °¨»ç ¹× ¼¼¹«ÀÚ¹®
È¿¼º±â°è°ø¾÷ µî ±â¾÷ÀμöÇÕº´
º¥Ã³±â¾÷ ÅõÀÚÀ¯Ä¡ ¹× IPOÄÁ¼³ÆÃ
»ï¼ºÁß¾Ó°³¹ß¢ß, Áøµµ±×·ì, ¼±°æ±×·ì ºÎµ¿»ê°³¹ß¿ë¿ª
Á¤º¸Åë½ÅºÎ À§ÃË »ç¾÷ÀÚÆò°¡ÀÚ¹®
°ñÇÁÀå(Áö»êCC, ¼ÛÃßCC, ÆÄ¶ó´ÙÀ̽ºCC µî)¼¼¹«
|
|
|

 |

°í·Á´ëÇб³ °æ¿µÇаú/°í·Á´ëÇб³´ëÇпø À繫·Ð Àü°ø.¼®»ç

»ïÀÏȸ°è¹ýÀÎ
ÀÎõ°æÃÑÀÚ¹®À§¿ø ¿ªÀÓ
Çö)Á¤ÀÏȸ°è¹ýÀÎ ±¸·ÎÁöÁ¡

Á¾ÇÕÀ¯¼±¹æ¼Û »ç¾÷ÀÚ Çã°¡ ¼±Á¤¿ë¿ª
°³¹ßºÎ´ã±Ý »êÁ¤¿ë¿ª(Çѱ¹°ü±¤°ø»ç)
¿ø°¡°è»êÁ¦µµ ±¸Ãà(Çѱ¹Àü·Â°ø»ç, Çѱ¹°¡½º¾ÈÀü°ø»ç, ¢ßµ¿¾ç¸ÅÁ÷ µî)
º¥Ã³±â¾÷ÅõÀÚÀ¯Ä¡ ¹× IPOÄÁ¼³ÆÃ
|
|
|

 |

´ë±¸ ½ÉÀΰí/°æºÏ´ëÇб³ °æ»ó´ë

¾ÈÁøÈ¸°è¹ýÀÎ
Çö)Á¤ÀÏȸ°è¹ýÀÎ ±¸·ÎÁöÁ¡

¾çõ±¸Ã», ±¸·Î±¸Ã» Áö¹æ¼¼ ½É»çÀ§¿ø
Çѱ¹µµ½ÃÁ¤ºñ Àü¹®°ü¸®Çùȸ ÀÚ¹®À§¿ø
¹Ù¸¥Àç°ÇÃàÀü±¹¿¬ÇÕȸ ÀÌ»ç
|
|
|

 |

¼º±Õ°ü´ë ȸ°è´ëÇпø ¼ö·á

¾ÈÁøÈ¸°è¹ýÀÎ / Çѱ¹½Å¿ëÆò°¡Á¤º¸ / ½ÅÇÑȸ°è¹ýÀÎ
°í¾ç¼¼¹«¼ °ú¼¼ÀüÀûºÎ½É»ç À§¿ø
Çö) ÆÄÁֽà ½Ã¼¼ µî ½ÉÀÇÀ§¿ø
Çö) (Àç)°í¾çÁö½ÄÁ¤º¸»ê¾÷ÁøÈï¿ø °¨»ç
Çö)Á¤ÀÏȸ°è¹ýÀÎ ÀÏ»êÁöÁ¡

ȸ°è°¨»ç ¹× Á¶»ç ¾÷¹«
Áö¹æ¼¼ ¹× Á¾ÇÕ¼¼¹« ÀÚ¹®
°æ¿µÀÏ¹Ý ÀÚ¹®
|
|
|

 |

¼º±Õ°ü´ë °æ¿µ

¾ÈÁøÈ¸°è¹ýÀÎ / ¾È°Çȸ°è¹ýÀÎ / ½ÅÇÑȸ°è¹ýÀÎ
Çö)Á¤ÀÏȸ°è¹ýÀÎ ÀÏ»êÁöÁ¡

Áö¹æÀÚÄ¡´Üü °¨»ç
º¥Ã³Ã¢¾÷ÀÚ¹®
¼¼¹«ÀÚ¹® (Á¶¼¼ºÒº¹, ¿ÜÅõ±â¾÷ ¹ýÀμ¼)
±â¾÷ Àμö ¹× ÇÕº´
|
|
|

 |

¼º±Õ°ü´ë °æ¿µ

»ïÀÏȸ°è¹ýÀÎ
Çö)Á¤ÀÏȸ°è¹ýÀÎ ÀÏ»êÁöÁ¡

Áö¹æÀÚÄ¡´Üü °¨»ç
°ø±â¾÷ °¨»ç
±â¾÷ Àμö ÇÕº´
Á¶¼¼ ºÒº¹

°èÁ¤°ú¸ñÇØ¼³¼ °øÀú
|
|
|
 |

dz»ý°í / ¼¿ï´ë »çȸ°úÇдë

ÇÑ¿µÈ¸°è¹ýÀÎ
Çѱ¹°øÀÎȸ°è»çȸ °æ¿µÆò°¡À§¿ø
Çö) ¼º³²½Ã °í¹®È¸°è»ç, »ê¾÷ÁøÈïÀç´Ü °¨»ç
Çö)Á¤ÀÏȸ°è¹ýÀÎ ºÐ´çÁöÁ¡

µ¿¾ç³ªÀÌ·Ð µî ȸ°è°¨»ç¾÷¹«¼öÇà
°ñÇÁÀå¾÷ Àü¹® ÄÁ¼³ÆÃ
ADMS M&A µî ¼öÇà

ÆíÀú¡°°ñÇÁ»ê¾÷ÀÇ ¼¼¹«È¸°è »ç·ÊÁý
|
|
|

 |

ÇѾç´ëÇб³ °æ¿µ´ëÇпø ȸ°èÇаú

Àü, ÀÌõ½Å¿ëÇùµ¿Á¶ÇÕ ±Ù¹«
Çö)Á¤ÀÏȸ°è¹ýÀÎ ºÐ´çÁöÁ¡

½Å¿ëÇùµ¿Á¶ÇÕ È¸°è°¨»ç ¹× °æ¿µÄÁ¼³ÆÃ
ºñ¿µ¸®¹ýÀÎÀÇ ¼¼¹«È¸°è °ü·Ã ÀÚ¹®
|
|
|

 |

¿¬¼¼´ë °æ¿µÇаú

¾È°Çȸ°è¹ýÀÎ/½Å¿ìȸ°è¹ýÀÎ
¼°Àü¹®Çб³ ÇÐÀå
Çö)Á¤ÀÏȸ°è¹ýÀÎ

°æÂû°øÁ¦È¸ »ç¾÷Ÿ´ç¼ººÐ¼® ÅõÀÚÀÚ¹®
ºÎµ¿»êÅõÀÚÀÚ¹®»ç(KARIC)
±¤ÁÖ½Ãû°¨»ç°ü(±¤ÁÖ½Ãû)
Áß¼Ò±â¾÷ÀÚ¹®À§¿ø(½Å¿ëº¸Áõ±â±Ý)
|
|
|
|
|
|